Originally posted by: ucjffj
okay so people are making two arguments:
1) medical treatments affect small populations
2) supply and demand
and for drug companies:
3) they need to recoup costs of failed drugs
let's look at drug companies. i don't see how 1 applies because pharmaceutical companies design drugs that'll affect the most people. more people will buy lipitor or viagra than will buy a geforce or pentium. drug companies aren't designing drugs for people with rare diseases, and instead are focusing on alzheimer since that'll affect more and more people as time goes on.
in regards to 2, for past decade it seems like of any other computer component, video cards are the hottest. and yet every year you can spend a set amount (say $150) and get something a lot better each year, despite the gpu getting much more complex and increasing demand.
in regards to 3, which is true, but seems more of an excuse to price gouge. the same principle applies to movie or music companies but you don't see the same profit margins. in fact pharamcy companies are the most profitable companies of any industry (at least from article i read in 2003)
thoughts?
Good criticisms.
Two moderating things:
1. Electronics companies usually act in oligopolic (what a great word) markets. For some reason, ATI and Nvidia can release comparable new products every year, that can compete with one another. Drug companies on the other hand tend to operate in monopolies. What is a competitior to Viagra? AZT? For some reason drug companies take longer to put out directly competing products. This could be due to the regulatory hurdles they have to pass, maybe their patent rights on what exactly counts as a differentiated product are more restrictive than in electronics, or maybe the drug companies have a tacit agreement to not compete too directly. Or maybe, researching drugs is just harder, if you want a blameless explanation. I doubt this one, though. If that were the case, you would likely see more than two companies competing in the hardware sector.
2. As mentioned before, demand for medical care is in a way, higher. Even if it doesn't appeal to as many people, those who want a drug want it really badly. So, an increase in price will scare away fewer customers. This is referred to as having an inelastic demand curve. In linear models, the elasticity is related to the slope of the curve. Drugs would have a curve that is nearly straight up, electronics might have a curve with a slope that is maybe at -1. As you move backward on the x axis (for quantity), the corresonding y value (for price) will go up much higher on the drug curve than on the electronics curve. This is what people are referring to when they say in the newspapers that a company is restricting supply. What they are really doing is raising the price. How much the price goes up is dependent on the elasticity of the demand curve.
Add these two together and you have an industry that can get away with raising the price higher because
a) there is no competitor to catch them
b) their customer base won't tell them to fvck off. They need that fix, man.